As shown in Fig. 1A, suppression of OGA activity using PUGNAc increased the levels of OGP in CCA cells 2.5‐fold in KKU‐213 and 3.0‐fold in KKU‐214, respectively. This evidence concerns the gene OGA and cholangiocarcinoma.